Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

SELL
$2.35 - $3.74 $105,515 - $167,926
-44,900 Closed
0 $0
Q4 2019

Jan 31, 2020

SELL
$1.6 - $2.43 $40,160 - $60,993
-25,100 Reduced 35.86%
44,900 $96,000
Q4 2018

Jan 24, 2019

BUY
$2.08 - $3.36 $20,800 - $33,600
10,000 Added 16.67%
70,000 $161,000
Q3 2018

Oct 15, 2018

BUY
$2.6 - $3.59 $156,000 - $215,400
60,000 New
60,000 $193,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track New Jersey Better Educational Savings Trust Portfolio

Follow New Jersey Better Educational Savings Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Jersey Better Educational Savings Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Jersey Better Educational Savings Trust with notifications on news.